NovoCure (NVCR) EBT (2014 - 2026)
NovoCure (NVCR) posted quarterly EBT of -$12.5 million for Q2 2026, up 64.4% year-on-year from -$7.6 million in Q2 2025, and up 82.02% on a QoQ basis from -$69.3 million in Q1 2026.
NovoCure (NVCR) EBT (2014 - 2026) Analysis & Trends
NovoCure (NVCR) has reported EBT for 13 consecutive years, with -$12.5 million the latest figure, recorded in Q2 2026.
- Quarterly EBT rose 64.4% year-over-year to -$12.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$152.7 million (down 7.48% YoY) and the FY2025 annual result came in at -$136.2 million, down 3.88% from the prior year.
- EBT improved to -$12.5 million in Q2 2026 per NVCR's latest filing, from -$69.3 million in the prior quarter.
- Over the last five years, EBT for NVCR reached as high as -$2.5 million in Q1 2022 and fell as low as -$69.3 million in Q1 2026.
- A 5-year average of -$34.6 million and a median of -$32.1 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2023 — EBT plunged 1931.01% — and 2026, when it jumped 64.4%.
- Year by year, EBT stood at -$32.6 million in 2022, then fell by 18.35% to -$38.5 million in 2023, then sank by 43.27% to -$55.2 million in 2024, then increased by 25.82% to -$41.0 million in 2025, then soared by 69.6% to -$12.5 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$12.5 million, -$69.3 million, and -$41.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NovoCure | 2.28 Bn | 1.85 Bn | 142.48 Mn | -12.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.45 Mn |
| Mar 31, 2026 | -69.26 Mn |
| Dec 31, 2025 | -40.95 Mn |
| Sep 30, 2025 | -30.02 Mn |
| Jun 30, 2025 | -34.98 Mn |
| Mar 31, 2025 | -30.30 Mn |
| Dec 31, 2024 | -55.21 Mn |
| Sep 30, 2024 | -21.59 Mn |
| Jun 30, 2024 | -22.73 Mn |
| Mar 31, 2024 | -31.64 Mn |
| Dec 31, 2023 | -38.53 Mn |
| Sep 30, 2023 | -48.22 Mn |
| Jun 30, 2023 | -53.90 Mn |
| Mar 31, 2023 | -51.08 Mn |
| Dec 31, 2022 | -32.56 Mn |
| Sep 30, 2022 | -23.42 Mn |
| Jun 30, 2022 | -23.36 Mn |
| Mar 31, 2022 | -2.52 Mn |
| Dec 31, 2021 | -25.57 Mn |
| Sep 30, 2021 | -10.53 Mn |